| 000 | 01919cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030237.0 | ||
| 008 | 100612s2010 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.09.M.Sc.2010.Ah.I | ||
| 100 | 0 | _aAhmed Mohamed Taha | |
| 245 | 1 | 0 |
_aInfluence of the CD14 genotype polymorphism on C - reactive protein levels in patients with coronary artery disease / _cAhmed Mohamed Taha ; Supervised Khaled Hussein Mohammed , Sanaa Sayed Abdelshafy , Mohammed Mohammed Khaled |
| 246 | 1 | 5 | _aاثر التحور الجينى لمستقبل سى دى 14 على مستوى بروتين سى المتفاعل الفائق الحساسية فى المرضى المصابين بأمراض الشرايين التاجية |
| 260 |
_aCairo : _bAhmed Mohamed Taha , _c2010 |
||
| 300 |
_a170P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Critical Care Medicine | ||
| 520 | _aInflammation is one of the major components of atherosclerosis which is the underlying disorder that leads to various diseases including coronary artery disease (CAD ) . CD14 receptor is an important mediator of inflammatory reactions and its expression is under genetic control . The allelic variant of the the CD14 polymorphism located in the promoter region of the CD14 gene is associated with receptor expression and ischemic risk | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCoronary artery disease | |
| 653 | 4 | _aInflammation | |
| 653 | 4 | _aPolymorphism | |
| 700 | 0 |
_aKhaled Hussein Mohammed , _eSupervisor |
|
| 700 | 0 |
_aMohammed Mohammed Khaled , _eSupervisor |
|
| 700 | 0 |
_aSanaa Sayed Abdelshafy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c30635 _d30635 |
||